Combined treatment with variceal ligation and β‐blockers ± nitrates to prevent recurrent variceal bleeding in cirrhosis. An updated systematic review
ConclusionsThe addition of drug therapy to EVL improves the efficacy of EVL alone. However, the addition of EVL to ß‐blockers and ISMN achieves a non‐significant decrease of rebleeding with no effect on mortality. Although combination therapy with EVL plus β‐blockers±ISMN is adequate to prevent rebleeding, β‐blockers+ISMN alone may be a valid alternative.This article is protected by copyright. All rights reserved.
Source: Liver International - Category: Gastroenterology Authors: Angela Puente, Virginia Hernández‐Gea, Isabel Graupera, Marta Roque, Alan Colomo, Maria Poca, Carles Aracil, Ignasi Gich, Carlos Guarner, Càndid Villanueva Tags: Reviews Source Type: research
More News: Bleeding | Cirrhosis | Gastroenterology | Isosorbide Mononitrate | Liver | Lower Endoscopy | Study | Urology & Nephrology